Loading clinical trials...
Loading clinical trials...
The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is: •is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Azienda Sanitaria Universitaria Friuli Centrale
Udine, Friuli Venezia Giulia, Italy
IRCCS Ospedale Policlinico San Martino
Genoa, Liguria, Italy
Fondazione IRCCS Mondino
Pavia, Lombardy, Italy
Fondazione IRCCS San Gerardo dei Tintori
Monza, Monza E Della Brianza, Italy
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
Milan, Italy
Ospedale San Paolo
Milan, Italy
Start Date
March 1, 2023
Primary Completion Date
March 31, 2024
Completion Date
April 30, 2024
Last Updated
January 2, 2024
90
ESTIMATED participants
FDG-PET
DIAGNOSTIC_TEST
Lead Sponsor
University of Milano Bicocca
NCT07477015
NCT06079294
NCT07133113
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions